Future GLP-1 trends: new drugs and therapies on the horizon The future of weight management may soon involve more than current GLP-1s: Amylin mimetics: These compounds mimic another satiety hormone and may complement GLP-1s. Mazdutide: A dual glucagon/GLP-1 agonist showing strong Phase 3 results and promising greater weight loss. Oral GLP-1s: Pills in development could improve convenience. Muscle-preserving combinations: Researchers are exploring co-therapies to prevent loss of lean mass during weight loss. Providers should prepare for a rapidly evolving landscape and educate patients about upcoming options. Key takeaways on GLP-1 trends for providers and patients Efficacy varies across drugs and doses
It helps to transport long-chain fatty acids into cell mitochondria where they can be burned up and used as fuel
They compound a wide range of medications beyond just semaglutide , including hormone replacement therapies, veterinary medications, and various injectable compounds
Glutathione IV for Liver Detox: Restore Energy and Support Repair Learn how glutathione supports antioxidant activity, what liver detox claims mean, and what to discuss before provider-reviewed IV therapy
This effect seems to be very important for the normalization of postprandial glucose (PPG) elevations, and potentially even more important than the insulinotropic effects of GLP-1 for maintaining PPG homeostasis [19]
Requires higher doses than subcutaneous
